NY State Senate Bill 2015-S7317A

Senate Bill S7317A

2015-2016 Legislative Session

Prohibits managed care providers, under the medical assistance program, from requiring prior authorization for the dispensing of buprenorphine for treatment of opioid addiction

download bill text pdf

Archive: Last Bill Status - In Assembly Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
May 17, 2016	referred to ways and means delivered to assembly passed senate
May 16, 2016	ordered to third reading cal.856 committee discharged and committed to rules
May 04, 2016	print number 7317a
May 04, 2016	amend and recommit to health
Apr 15, 2016	referred to health

Votes

- May 17, 2016 - Floor Vote
  S7317A
  
  57
  
  Aye
  
  1
  
  Nay
  
  0
  
  Absent
  
  5
  
  Excused
  
  0
  
  Abstained
  - - Floor Vote: May 17, 2016
      
      aye (57)
      
      Addabbo Jr.
      
      Akshar
      
      Amedore
      
      Avella
      
      Bonacic
      
      Boyle
      
      Carlucci
      
      Croci
      
      DeFrancisco
      
      Dilan
      
      Espaillat
      
      Farley
      
      Felder
      
      Flanagan
      
      Funke
      
      Gallivan
      
      Gianaris
      
      Golden
      
      Griffo
      
      Hamilton
      
      Hannon
      
      Hassell-Thompson
      
      Hoylman-Sigal
      
      Kaminsky
      
      Kennedy
      
      Klein
      
      Krueger
      
      LaValle
      
      Lanza
      
      Larkin
      
      Latimer
      
      Little
      
      Marcellino
      
      Martins
      
      Montgomery
      
      Murphy
      
      O'Mara
      
      Ortt
      
      Panepinto
      
      Parker
      
      Peralta
      
      Perkins
      
      Persaud
      
      Ranzenhofer
      
      Ritchie
      
      Rivera
      
      Robach
      
      Sanders Jr.
      
      Savino
      
      Serino
      
      Serrano
      
      Squadron
      
      Stavisky
      
      Stewart-Cousins
      
      Valesky
      
      Venditto
      
      Young
      
      nay (1)
      
      Comrie
      
      excused (5)
      
      Breslin
      
      Diaz
      
      Marchione
      
      Nozzolio
      
      Seward
  May 16, 2016 - Rules Committee Vote
  S7317A
  
  24
  
  Aye
  
  0
  
  Nay
  
  1
  
  Aye with Reservations
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  - - Rules Committee Vote: May 16, 2016
      
      aye (24)
      
      Bonacic
      
      Breslin
      
      Carlucci
      
      DeFrancisco
      
      Espaillat
      
      Farley
      
      Flanagan
      
      Gianaris
      
      Golden
      
      Hannon
      
      Hassell-Thompson
      
      Krueger
      
      LaValle
      
      Lanza
      
      Larkin
      
      Little
      
      Marcellino
      
      Montgomery
      
      Parker
      
      Perkins
      
      Robach
      
      Stewart-Cousins
      
      Valesky
      
      Young
      
      aye wr (1)
      
      Dilan

Bill Amendments

Original

A (Active)

co-Sponsors

2015-S7317 - Details

See Assembly Version of this Bill:: A9937
Current Committee:: Assembly Ways And Means
Law Section:: Social Services Law
Laws Affected:: Amd §364-j, Soc Serv L

2015-S7317 - Summary

Prohibits managed care providers, under the medical assistance program, from requiring prior authorization for the dispensing of buprenorphine for treatment of opioid addiction.

2015-S7317 - Sponsor Memo

                                 BILL NUMBER:  S7317

 TITLE OF BILL :

An act to amend the social services law, in relation to prohibiting
prior authorization for the dispensing of buprenorphine for the
treatment of opioid addiction

 PURPOSE :

Prohibits managed care providers, under the medical assistance
program, from requiring prior authorization for the dispensing of
buprenorphine for treatment of opioid addiction.

 SUMMARY OF PROVISIONS :

Section 1 amends the social service law by adding a new subdivision
26-a which establishes that no managed care provider shall require
prior authorization for any prescription or renewal thereof for the
dispensing of buprenorphine which is prescribed as a treatment for
opioid addiction

Section 2 establishes the effective date.

 JUSTIFICATION :

Opioid addiction in New York State has increased at an alarming rate.
Now, more than ever, it is imperative that physicians are able to
easily prescribe treatment to those struggling with addiction.
Buprenorphine is an effective treatment for people with opioid
addiction, it not only helps to reduce withdrawal symptoms and
cravings, but also helps the individual overcome this debilitating
addiction. Although highly effective, physicians are reluctant to even
obtain the qualifications necessary to prescribe this treatment
because of the bureaucratic constraints. Prior authorization requires
doctors to dedicate an exorbitant amount of time to simply provide
patients with a prescription already decided to be appropriate for the
patient's addiction recovery. This burdensome delay can last anywhere
from forty-eight hours to over a week, often times resulting in a
relapse for many of these individuals. Buprenorphine is an incredible
tool not only helping to save lives, but also allowing individuals to
obtain the comprehensive treatment they so desperately need.
Eradicating the prior approval process for Buprenorphine will ensure
greater access to this crucial piece of the recovery process.

 LEGISLATIVE HISTORY :

New bill

 FISCAL IMPLICATIONS :

None.

 EFFECTIVE DATE :
This act shall take effect immediately, provided that the amendment to
section 364-j of the social services law, made by section one of this
act, shall not affect the expiration and repeal of such section, and
shall expire and be deemed repealed therewith.

2015-S7317 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  7317

                            I N  S E N A T E

                             April 15, 2016
                               ___________

Introduced  by  Sens.  MURPHY,  AMEDORE,  ORTT -- read twice and ordered
  printed, and when printed to be committed to the Committee on Health

AN ACT to amend the social services  law,  in  relation  to  prohibiting
  prior authorization for the dispensing of buprenorphine for the treat-
  ment of opioid addiction

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 364-j of the social  services  law  is  amended  by
adding a new subdivision 26-a to read as follows:
  26-A.  NO  MANAGED CARE PROVIDER SHALL REQUIRE PRIOR AUTHORIZATION FOR
ANY PRESCRIPTION OR RENEWAL THEREOF FOR THE DISPENSING OF  BUPRENORPHINE
WHICH IS PRESCRIBED AS A TREATMENT FOR OPIOID ADDICTION.
  S  2. This act shall take effect immediately, provided that the amend-
ment to section 364-j of the social services law, made by section one of
this act, shall not affect the expiration and repeal  of  such  section,
and shall expire and be deemed repealed therewith.







 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD14865-01-6

co-Sponsors

View additional co-sponsors

2015-S7317A (ACTIVE) - Details

See Assembly Version of this Bill:: A9937
Current Committee:: Assembly Ways And Means
Law Section:: Social Services Law
Laws Affected:: Amd §364-j, Soc Serv L

2015-S7317A (ACTIVE) - Summary

Prohibits managed care providers, under the medical assistance program, from requiring prior authorization for the dispensing of buprenorphine for treatment of opioid addiction.

2015-S7317A (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S7317A

 TITLE OF BILL :

An act to amend the social services law, in relation to prohibiting
prior authorization for the dispensing of buprenorphine for the
treatment of opioid addiction

 PURPOSE :

Prohibits managed care providers, under the medical assistance
program, from requiring prior authorization for the dispensing of
buprenorphine for treatment of opioid addiction.

 SUMMARY OF PROVISIONS :

Section 1 amends the social service law by adding a new subdivision
26-b which establishes that no managed care provider shall require
prior authorization for any prescription or renewal thereof for the
dispensing of buprenorphine which is prescribed as a treatment for
opioid addiction

Section 2 establishes the effective date.

 JUSTIFICATION :

Opioid addiction in New York State has increased at an alarming rate.
Now, more than ever, it is imperative that physicians are able to
easily prescribe treatment to those struggling with addiction.
Buprenorphine is an effective treatment for people with opioid
addiction, it not only helps to reduce withdrawal symptoms and
cravings, but also helps the individual overcome this debilitating
addiction. Although highly effective, physicians are reluctant to even
obtain the qualifications necessary to prescribe this treatment
because of the bureaucratic constraints. Prior authorization requires
doctors to dedicate an exorbitant amount of time to simply provide
patients with a prescription already decided to be appropriate for the
patient's addiction recovery. This burdensome delay can last anywhere
from forty-eight hours to over a week, often times resulting in a
relapse for many of these individuals. Buprenorphine is an incredible
tool not only helping to save lives, but also allowing individuals to
obtain the comprehensive treatment they so desperately need.
Eradicating the prior approval process for Buprenorphine will ensure
greater access to this crucial piece of the recovery process.

 LEGISLATIVE HISTORY :

New bill

 FISCAL IMPLICATIONS :

None.

 EFFECTIVE DATE :
This act shall take effect immediately, provided that the amendment to
section 364-j of the social services law, made by section one of this
act, shall not affect the expiration and repeal of such section, and
shall expire and be deemed repealed therewith.

2015-S7317A (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7317--A

                            I N  S E N A T E

                             April 15, 2016
                               ___________

Introduced  by  Sens.  MURPHY,  AMEDORE, ORTT, LATIMER -- read twice and
  ordered printed, and when printed to be committed to the Committee  on
  Health  --  committee  discharged,  bill amended, ordered reprinted as
  amended and recommitted to said committee

AN ACT to amend the social services  law,  in  relation  to  prohibiting
  prior authorization for the dispensing of buprenorphine for the treat-
  ment of opioid addiction

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 364-j of the social  services  law  is  amended  by
adding a new subdivision 26-b to read as follows:
  26-B.  NO  MANAGED CARE PROVIDER SHALL REQUIRE PRIOR AUTHORIZATION FOR
ANY PRESCRIPTION OR RENEWAL THEREOF FOR THE DISPENSING OF  BUPRENORPHINE
WHICH IS PRESCRIBED AS A TREATMENT FOR OPIOID ADDICTION.
  S  2. This act shall take effect immediately, provided that the amend-
ment to section 364-j of the social services law, made by section one of
this act, shall not affect the expiration and repeal  of  such  section,
and shall expire and be deemed repealed therewith.






 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD14865-02-6

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S7317A

Share this bill

Sponsored By

Archive: Last Bill Status - In Assembly Committee

Bill Amendments

co-Sponsors

2015-S7317 - Details

2015-S7317 - Summary

2015-S7317 - Sponsor Memo

2015-S7317 - Bill Text download pdf

co-Sponsors

2015-S7317A (ACTIVE) - Details

2015-S7317A (ACTIVE) - Summary

2015-S7317A (ACTIVE) - Sponsor Memo

2015-S7317A (ACTIVE) - Bill Text download pdf

Comments